Axonal degeneration and progressive neurologic disability in multiple sclerosis (Q44495164)

3 December 2017

title

Axonal degeneration and progressive neurologic disability in multiple sclerosis (English)

1 reference

3 December 2017

0 references

0 references

Carl Bjartmar

1 reference

3 December 2017

Bruce D Trapp

series ordinal

1 reference

3 December 2017

publication date

1 January 2003

1 reference

3 December 2017

published in

Neurotoxicity Research

1 reference

3 December 2017

1 reference

3 December 2017

issue

1-2

1 reference

3 December 2017

page(s)

157-164

1 reference

Axonal loss in normal-appearing white matter in a patient with acute MS.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03033380

Total brain N-acetylaspartate: a new measure of disease load in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033380

Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033380

Synthesis of N-acetyl-l-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033380

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033380

A Wallerian degeneration pattern in patients at risk for MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033380

A Longitudinal Magnetic Resonance Imaging Study of the Cervical Cord in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033380

The longstanding MS lesion. A quantitative MRI and electron microscopic study

21 January 2018

1 reference

12 December 2020

Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions

1 reference

12 December 2020

Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis

1 reference

12 December 2020

A real-time insight into disease progression and the role of axonal injury in multiple sclerosis

1 reference

12 December 2020

Demyelinating diseases--new pathological insights, new therapeutic targets

1 reference

12 December 2020

Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy

1 reference

12 December 2020

Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients

1 reference

12 December 2020

N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction

1 reference

12 December 2020

Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences

1 reference

12 December 2020

Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives

1 reference

12 December 2020

Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.

1 reference

12 December 2020

Axonal pathology in demyelinating diseases

1 reference

12 December 2020

Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss

1 reference

12 December 2020

Immunohistochemical localization of N-acetylaspartate in rat brain

1 reference

12 December 2020

Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis

1 reference

12 December 2020

Axonal changes in chronic demyelinated cervical spinal cord plaques

1 reference

12 December 2020

Spinal cord axonal loss in multiple sclerosis: a post-mortem study

1 reference

12 December 2020

Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells

1 reference

12 December 2020

N-Acetylation of L-aspartate in the nervous system: differential distribution of a specific enzyme

1 reference

12 December 2020

Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons.

1 reference

12 December 2020

Reversible decreases in N-acetylaspartate after acute brain injury

1 reference

12 December 2020

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions

1 reference

12 December 2020

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group

1 reference

12 December 2020

Glutamate excitotoxicity in a model of multiple sclerosis

1 reference

12 December 2020

Relapses and progression of disability in multiple sclerosis

1 reference

12 December 2020

Axonal pathology in myelin disorders

1 reference

12 December 2020

Selecting relapsing remitting multiple sclerosis patients for treatment: the case for early treatment

1 reference

12 December 2020

Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis

1 reference

12 December 2020

Axonal pathology in multiple sclerosis. A historical note

1 reference

12 December 2020

Imaging axonal damage of normal-appearing white matter in multiple sclerosis

1 reference

12 December 2020

Magnetic resonance imaging in the monitoring of disease progression in multiple sclerosis

1 reference

12 December 2020

Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis

1 reference

12 December 2020

Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies

1 reference

12 December 2020

Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons.

1 reference

12 December 2020

Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability

1 reference

12 December 2020

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study

1 reference

12 December 2020

Effects of PMP22 duplication and deletions on the axonal cytoskeleton

1 reference

12 December 2020

Spinal cord atrophy and disability in multiple sclerosis

1 reference

12 December 2020

Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo

1 reference

12 December 2020

Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32

1 reference

12 December 2020

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis

1 reference

12 December 2020

Axonal transection in the lesions of multiple sclerosis

1 reference

12 December 2020

Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis

1 reference

12 December 2020

N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve

1 reference

12 December 2020

Axonal damage in acute multiple sclerosis lesions

1 reference

12 December 2020

Axonal swellings and degeneration in mice lacking the major proteolipid of myelin

1 reference

12 December 2020

Management of Multiple Sclerosis

1 reference

12 December 2020

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study

1 reference

12 December 2020

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis

1 reference

12 December 2020

1 reference

12 December 2020

Cortical lesions in multiple sclerosis

1 reference

12 December 2020

Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport

1 reference

12 December 2020

Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03033380

1 reference

3 December 2017

1 reference